A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery
- PMID: 31097980
- PMCID: PMC6511952
- DOI: 10.1021/acsmedchemlett.9b00107
A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery
Abstract
Medicinal chemists have increasing opportunities to transition from the pharmaceutical industry to academic medical centers interested in translational research. This Viewpoint highlights some of the differences between these two cultures and strategies to succeed in academic drug discovery.
Conflict of interest statement
The author declares no competing financial interest.
References
-
- Valdivia W. D.University start-ups: Critical for improving technology transfer. In Center for Technology Innovation at Brookings, 2013; https://www.brookings.edu/wp-content/uploads/2016/06/Valdivia_Tech-Trans....
-
- Hunter J.; Stephens S. Is open innovation the way forward for big pharma?. Nat. Rev. Drug Discovery 2010, 9 (2), 87–88. 10.1038/nrd3099. - DOI
Publication types
LinkOut - more resources
Full Text Sources
